UBS O'Connor’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-44,247
| Closed | -$250K | – | 469 |
|
|
2023
Q4 | $250K | Sell |
44,247
-41,231
| -48% | -$233K | 0.01% | 375 |
|
|
2023
Q3 | $409K | Sell |
85,478
-15,000
| -15% | -$71.9K | 0.01% | 399 |
|
|
2023
Q2 | $688K | Buy |
100,478
+4,950
| +5% | +$33.9K | 0.01% | 408 |
|
|
2023
Q1 | $744K | Buy |
+95,528
| New | +$744K | 0.02% | 425 |
|
|
2022
Q4 | – | Sell |
-91,615
| Closed | -$748K | – | 129 |
|
|
2022
Q3 | $748K | Sell |
91,615
-10,032
| -10% | -$81.9K | 0.01% | 760 |
|
|
2022
Q2 | $983K | Buy |
+101,647
| New | +$983K | 0.01% | 759 |
|